Trastuzumab emtansine in breast cancer

Author： Dirix Luc Y   Rutten Annemie   Huget Philippe   Dirix Marie  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.4, 2013-04, pp. : 607-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer

By Burris Howard A  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 807-819

Informa Healthcare

Access to resources Recommend Favorite

A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab

By Rueckert S   Ruehl I   Kahlert S   Konecny G   Untch M  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 853-866

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy of breast cancer

By Wright Stephen E  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 479-490

Informa Healthcare

Access to resources Recommend Favorite

Autofluorescence of Breast Cancer Proteins

By  

Current Metabolomics, Vol. 6, Iss. 1, 2018-01 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase-2 and chemoprevention of breast cancer

By Davies G.L.S.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 495-499

Elsevier

Access to resources Recommend Favorite